At the end of September 2012, the EMCDDA and Europol examined the available information on a new psychoactive substance 5-(2-aminopropyl)indole (commonly known by the abbreviation ‘5-IT’), through a joint assessment. The two organisations concluded that sufficient information had been accumulated to merit the production of a Joint Report on 5-(2-aminopropyl)indole as stipulated by Article 5.1 of the Council Decision 2005/387/JHA.

Table of contents:
Introduction
Information collection process
Information required by Article 5.2 of the Decision
Information from the EMA as requested by Article 5.3 of the Decision
Summary of findings
Conclusions

Annexes
Annex 1 — Main information sources
Annex 2 — Details of seizures and collected samples of 5-(2-aminopropyl)indole (5-IT) reported to the EMCDDA
Annex 3 — Deaths associated with 5-(2-aminopropylindole(5-IT) reported to the EMCDDA